Table 7.

Current list of available vaccines and their efficiency

S. no.	Vaccine Name clinical Trail id	Developed countries	Time line doses	% efficiency (%)	Ag type	Study evolution	Status	References
1	Pfizer (BNT162b2) NCT04368728	USA	21 days b/w to doses	95	mRNA	Tolerability and immunogenicity from different strain	In use	Polack et al. (2020)
2	Moderna (mRNA-1273) NCT04470427	USA	28 days	94	mRNA	Neutralization against UK variant strain B.1.351varient	In use	Wu et al. (2021)
3	Covaxin (BBV152) NCT04471519	India	28 days	50	In activated	Neutralization against UK variant strain	In use	Ella et al. (2021)
4	Covishiled AZD1222 NCT04516746	UK	28 days	65	Viral vector	Neutralization against B.1.1.7 variant	In use	Voysey et al. (2021)
5	Sputnik V NCT04530396)	Russian	21 days	91	Viral vector	Immune system	In use	Jones and Roy (2021)
6	Jassen (Johnson & Johnson) Ad26.CoV2.S NCT04505722	USA	28 days	66	Viral vector	Effective against severe condition	In Use	Sadoff et al. (2021)
7	Corona Vac NCT04456595	China	14 days	50.4	Inactivated	Effective against UK, South African variants	In use	Wang et al. (2021)
8	BBIBP NCT04560881	China	21 days	79.3	Inactivated	Variant neutralization	In use	Wang et al. (2020)
9	EpiVacCorona NCT04527575	Russia	21 days	90	Peptide	Increased immune response	In use	Doroftei et al. (2021)
10	Convidecia NCT04526990	China	21 days	65	Viral Vector	Tolerability and immunogenicity from different strain	In use	Zhu et al. (2020)